Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

Method of Preparing a Production Intermediate For HIV Protease Inhibitors

  • Read more about Method of Preparing a Production Intermediate For HIV Protease Inhibitors
US Application 60/264,165
Filed on 2001-01-24

Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses

  • Read more about Recombinant Non-Replicating Virus Expressing GM-CSF and Uses Thereof to Enhance Immune Responses
US Application 60/211,717
Filed on 2000-06-15

Specific Binding Agents for KSHV vIL-6 That Neutralize a Biological Activity

  • Read more about Specific Binding Agents for KSHV vIL-6 That Neutralize a Biological Activity
US Application 60/221,719
Filed on 2000-07-31

Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins

  • Read more about Enhanced Homologous Recombination Mediated by Lambda Recombination Proteins
US Application 60/225,164
Filed on 2000-08-14

Diazeniumdiolates That Generate Superoxide As Well AS Nitric Oxide And Thus Serve As Peroxynitrite Generators

  • Read more about Diazeniumdiolates That Generate Superoxide As Well AS Nitric Oxide And Thus Serve As Peroxynitrite Generators
US Application 60/209,067
Filed on 2000-06-02

Nucleic Acids For Transgene Expression

  • Read more about Nucleic Acids For Transgene Expression
US Application 60/281,560
Filed on 2001-04-04

XAGE-1, A GENE EXPRESSED IN MULTIPLE CANCERS, AND USES THEREOF

  • Read more about XAGE-1, A GENE EXPRESSED IN MULTIPLE CANCERS, AND USES THEREOF
US Application 60/229,684
Filed on 2000-09-01

Immunotherapy In HIV Infeted Persons Using Vaccines After Multi-Drug Treatment

  • Read more about Immunotherapy In HIV Infeted Persons Using Vaccines After Multi-Drug Treatment
US Application 60/200,445
Filed on 2000-04-28

A Rev Tat Nef (Retinef) Chimeric Protein as a Component of an HIV-I Vaccine.

  • Read more about A Rev Tat Nef (Retinef) Chimeric Protein as a Component of an HIV-I Vaccine.
US Application 60/332,433
Filed on 2001-11-16

Immunogenicity Using a Combination of DNA and Vaccinia Virus Vector Vaccines

  • Read more about Immunogenicity Using a Combination of DNA and Vaccinia Virus Vector Vaccines
US Application 60/200,444
Filed on 2000-04-28

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 196
  • Page 197
  • Page 198
  • Page 199
  • Page 200
  • Page 201
  • Page 202
  • Page 203
  • Page 204
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health